Caption Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.6M	Buy	133,900 +8,900	+7%	+$1.54M	1.08%	162
2025 Q4	$22.8M	Buy	125,000 +100,000	+400%	+$14M	1.01%	151
2025 Q3	$3.04M	Hold	25,000	–	–	0.18%	665
2025 Q2	$2.61M	Sell	25,000 -27,200	-52%	-$2.88M	0.24%	636
2025 Q1	$6.09M	Sell	52,200 -76,700	-60%	-$8.74M	0.28%	326
2024 Q4	$10.9M	Buy	128,900 +93,900	+268%	+$8.64M	0.45%	173
2024 Q3	$3.15M	Buy	+35,000	New	+$3.06M	0.34%	430
2024 Q2	–	Sell	-38,500	Closed	-$3.07M	–	1183
2024 Q1	$3.07M	Buy	+38,500	New	+$3.23M	0.34%	424
2023 Q4	–	Sell	-10,100	Closed	-$706K	–	1361
2023 Q3	$706K	Sell	10,100 -17,400	-63%	-$1.3M	0.09%	864
2023 Q2	$1.98M	Sell	27,500 -2,500	-8%	-$184K	0.35%	496
2023 Q1	$1.85M	Sell	30,000 -5,000	-14%	-$328K	0.4%	459
2022 Q4	$2.7M	Buy	+35,000	New	+$2.09M	0.46%	478
2022 Q3	–	Sell	-195,000	Closed	-$7.47M	–	1512
2022 Q2	$7.47M	Buy	195,000 +157,500	+420%	+$4.98M	0.67%	255
2022 Q1	$1.55M	Sell	37,500 -2,500	-6%	-$77.5K	0.1%	839
2021 Q4	$1.51M	Buy	+40,000	New	+$1.47M	0.09%	889
2020 Q2	–	Sell	-17,500	Closed	-$1.03M	–	947
2020 Q1	$1.03M	Sell	17,500 -37,500	-68%	-$3.06M	0.34%	396
2019 Q4	$5.68M	Sell	55,000 -225,400	-80%	-$9.1M	1.21%	143
2019 Q3	$5.67M	Buy	280,400 +215,400	+331%	+$5.53M	1.8%	94
2019 Q2	$1.67M	Sell	65,000 -22,500	-26%	-$451K	0.58%	283
2019 Q1	$1.25M	Buy	+87,500	New	+$812K	0.44%	303